Zentalis Pharmaceuticals, Inc.
ZNTL
$4.14
-$0.01-0.24%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 211.76M | 245.89M | 280.70M | 303.43M | 332.45M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.34M | 7.30M | 7.61M | 8.17M | 10.43M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 218.10M | 253.19M | 288.30M | 311.60M | 342.88M |
|
|
|||||
| Total Current Assets | 218.10M | 253.19M | 288.30M | 311.60M | 342.88M |
| Net Property, Plant & Equipment | 28.25M | 29.04M | 33.12M | 34.26M | 35.17M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.72M | 6.74M | 5.83M | 5.85M | 5.97M |
| Total Assets | 253.07M | 288.97M | 327.25M | 351.71M | 384.02M |
|
|
|||||
| Total Accounts Payable | 7.38M | 7.21M | 7.03M | 3.72M | 7.77M |
| Total Accrued Expenses | 23.54M | 25.28M | 25.89M | 31.18M | 38.15M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.00M | 3.87M | 3.75M | 3.63M | 3.51M |
| Total Finance Division Other Current Liabilities | 317.00K | 194.00K | 500.00K | 500.00K | -- |
| Total Other Current Liabilities | 317.00K | 194.00K | 500.00K | 500.00K | -- |
| Total Current Liabilities | 35.24M | 36.56M | 37.17M | 39.02M | 49.43M |
|
|
|||||
| Total Current Liabilities | 35.24M | 36.56M | 37.17M | 39.02M | 49.43M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 34.65M | 35.70M | 36.71M | 37.69M | 38.65M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 500.00K | 500.00K | 500.00K | 500.00K | 558.00K |
| Total Liabilities | 70.39M | 72.76M | 74.38M | 77.21M | 88.64M |
|
|
|||||
| Common Stock & APIC | 1.41B | 1.41B | 1.41B | 1.40B | 1.40B |
| Retained Earnings | -1.23B | -1.19B | -1.16B | -1.13B | -1.10B |
| Treasury Stock & Other | -50.00K | 196.00K | 186.00K | 59.00K | 358.00K |
| Total Common Equity | 182.68M | 216.20M | 252.87M | 274.50M | 295.38M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 182.68M | 216.20M | 252.87M | 274.50M | 295.38M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 182.68M | 216.20M | 252.87M | 274.50M | 295.38M |
|
|
|||||